- Home
- RVTY vs OWL Comparison
RVTY vs OWL Comparison
Compare RVTY & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVTY | OWL |
|---|---|---|
| Founded | 1937 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 9.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RVTY | OWL |
|---|---|---|
| Price | $95.74 | $12.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 15 |
| Target Price | ★ $113.00 | $20.57 |
| AVG Volume (30 Days) | 1.6M | ★ 26.1M |
| Earning Date | 02-02-2026 | 02-05-2026 |
| Dividend Yield | 0.29% | ★ 7.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.07 | 0.10 |
| Revenue | $2,856,051,000.00 | ★ $2,870,178,000.00 |
| Revenue This Year | $6.06 | $12.01 |
| Revenue Next Year | $5.15 | $15.55 |
| P/E Ratio | ★ $46.68 | $123.00 |
| Revenue Growth | 3.67 | ★ 25.04 |
| 52 Week Low | $81.36 | $10.88 |
| 52 Week High | $120.39 | $24.28 |
Technical Indicators
Market Signals| Indicator | RVTY | OWL |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 33.48 |
| Support Level | $93.70 | $11.99 |
| Resistance Level | $106.55 | $13.10 |
| Average True Range (ATR) | 4.33 | 0.72 |
| MACD | -1.62 | -0.07 |
| Stochastic Oscillator | 15.05 | 34.14 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About OWL Blue Owl Capital Inc.
Blue Owl Capital is one of the world's largest alternative-asset managers, $295.6 billion in total managed assets, including $183.8 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, (with $68.8 billion in total AUM and $40.2 billion in fee-earning AUM), private credit ($152.1 billion/$97.3 billion), and real estate/real assets ($74.7 billion/$46.3 billion). The firm primarily serves institutional investors (68% of AUM) and high-net-worth individuals (32%). The firm operates through more than 20 offices in the Americas, and the EMEA and Asia-Pacific regions.